Clinical Bioequivalence Study on Two Paracetamol Tablet Formulations

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The objective of the study is to compare the bioavailability of a generic product of paracetamol (immediate‐release) with that of a reference product when administered to healthy volunteers under fasting condition. The test product is Fortolin Tab 500mg manufactured by Fortune Pharmacal Co. Ltd., and the reference product is Panadol Caplet 500mg manufactured by GlaxoSmithKline (Dungarvan) Ltd. The plasma pharmacokinetic data of paracetamol obtained from two formulations will be used to evaluate the interchangeability of the products.
Epistemonikos ID: 4a5b7c92828f36ccd443c2ad2ff59bc0eb41139c
First added on: May 21, 2024